- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by ArmaGen, Inc
Total 37104 results
-
AmgenRecruitingExtensive Stage Small Cell Lung CancerKorea, Republic of, United States, Netherlands, Taiwan, Switzerland, Spain, Canada, Israel, Germany, France, Belgium, Australia, Japan, Italy, Denmark
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Italy, Finland and more
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction CancerKorea, Republic of, Taiwan, Japan, Singapore, United States
-
AmgenRecruitingActive Juvenile Psoriatic ArthritisSpain, Turkey, Belgium, France, Greece, Italy, United Kingdom, Austria, Germany, Netherlands, Poland, Romania, Lithuania, South Africa, Portugal
-
AmgenRecruitingDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicUnited States, Korea, Republic of, Germany, Spain, Italy, Israel, Japan, Serbia, Argentina, Greece, Mexico, Poland, Chile, Austria, France, Portugal, Romania, Switzerland, United Kingdom
-
AmgenCompleted
-
AmgenTerminatedDyslipidemiaBelgium, Denmark, Germany, Sweden, France, Italy, Portugal
-
AmgenCompletedDyslipidemiaUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Czechia, Hungary, Taiwan, Colombia, Poland, Russian Federation, Switzerland, Korea, Republic of, Mexico, ... and more
-
AmgenActive, not recruitingAtopic DermatitisKorea, Republic of, United States, Turkey, Hong Kong, United Kingdom, Australia, Brazil, Canada, Argentina
-
AmgenCompletedGiant Cell Tumor of BoneAustralia, France, United States, Spain, Italy, Poland, Sweden, United Kingdom
-
AmgenCompletedSystemic Lupus ErythematosusUnited States
-
AmgenCompleted
-
AmgenNo longer availableRelapsed/Refractory B-Precursor Acute Lymphoblastic LeukemiaUnited States, Italy, Germany, Austria, France, Switzerland, United Kingdom
-
AmgenActive, not recruitingRelapsed/Refractory Small Cell Lung CancerUnited States, Belgium, Italy, Spain, Portugal, Austria, Greece, Korea, Republic of, Denmark, Netherlands, Germany, France, Taiwan, Japan, United Kingdom, Poland, Switzerland, Singapore
-
AmgenCompletedGout | Chronic Uncontrolled Gout | Uncontrolled GoutUnited States
-
AmgenActive, not recruitingPalmoplantar PustulosisJapan
-
AmgenTerminatedLupus NephritisSpain, Brazil, Taiwan, Thailand, Croatia, Serbia, United States, Malaysia, Poland, Philippines, Argentina, Israel
-
AmgenActive, not recruitingIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Australia, Japan, Canada, Taiwan, Netherlands, Italy, Chile, Greece, Mexico, Germany, France, Argentina, Poland, Turkey, South Africa, United Kingdom
-
AmgenTerminatedSystemic Lupus ErythematosusUnited States, Spain, Serbia, Mexico, Poland, Greece, Argentina, India, Taiwan
-
AmgenCompletedChronic Myelomonocytic Leukemia | Higher Risk Myelodysplastic SyndromeUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
AmgenWithdrawn
-
AmgenCompletedMigraine HeadacheUnited States, Austria, Australia, Czechia, Finland, France, Hungary, Italy, Poland, Portugal, Spain, United Kingdom
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
AmgenCompletedSystemic Lupus Erythematosus (SLE)United States, Korea, Republic of, Australia, Spain, Hungary, Bulgaria, Italy, Mexico, Germany, Japan, France, Greece, Czechia, Argentina, Portugal, Poland, Russian Federation, Hong Kong, Canada
-
AmgenCompletedAdvanced Non CNS TumorsUnited States, Belgium, Spain, France, Canada, Italy, Switzerland
-
AmgenCompletedPlaque PsoriasisUnited States, Poland, Canada, Germany, Estonia, Latvia
-
AmgenTerminatedGastric and Gastroesophageal Junction AdenocarcinomaKorea, Republic of, Taiwan, Spain, Austria, United States, France, Japan, Germany, Netherlands
-
AmgenCompleted
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
AmgenCompletedPsoriasisUnited States, Poland, Canada, Germany, Estonia, Georgia, Hungary, Latvia
-
AmgenCompleted
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
AmgenActive, not recruitingNon-small Cell Lung CancerBelgium, Spain, United States, Denmark, Sweden, France, Turkey, Italy, Germany, Netherlands
-
AmgenCompletedArthritis, PsoriaticNetherlands
-
AmgenWithdrawn
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompleted
-
AmgenCompletedHepatic ImpairmentUnited States
-
AmgenCompletedElectrocardiographyUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsVasculitis | Systemic Lupus Erythematosus (SLE)Switzerland
-
AmgenCompletedSystemic Lupus ErythematosusUnited States, Poland, Germany, France